Laurence Bozec

1.1k total citations
26 papers, 455 citations indexed

About

Laurence Bozec is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Laurence Bozec has authored 26 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Laurence Bozec's work include COVID-19 and healthcare impacts (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Laurence Bozec is often cited by papers focused on COVID-19 and healthcare impacts (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Laurence Bozec collaborates with scholars based in France, United States and Monaco. Laurence Bozec's co-authors include J. L. Misset, Esteban Cvitkovic, Philippe Beuzeboc, P Pouillart, Véronique Dièras, N. Azli, A. Riva, Salima Kalla, Hugues Bourgeois and C Jasmin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Laurence Bozec

26 papers receiving 451 citations

Peers

Countries citing papers authored by Laurence Bozec

Since Specialization

Citations

This map shows the geographic impact of Laurence Bozec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Bozec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Bozec more than expected).

Fields of papers citing papers by Laurence Bozec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Bozec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Bozec. The network helps show where Laurence Bozec may publish in the future.

Co-authorship network of co-authors of Laurence Bozec

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Bozec. A scholar is included among the top collaborators of Laurence Bozec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Bozec. Laurence Bozec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biomarkers and Prognostic Stratification of Squamous Cell Carcinoma of the Oral Cavity in Young Adults: How to Personalize Therapeutic Management? 2024 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), (unknown), Christophe Le Tourneau, (unknown), Nathalie Badois, Maria Lesnik, (unknown), Laurence Bozec, (unknown), Olivier Choussy	1
2	NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08) 2023 ·SHILAP Revista de lepidopterología ·Jérôme Fayette, Caroline Even, Laurence Digue, Lionnel Geoffrois, Frédéric Rolland, Didier Cupissol, J. Guigay, Christophe Le Tourneau, (unknown), Sylvie Zanetta, Laurence Bozec, Christian Borel, (unknown), Valérie Costes‐Martineau, (unknown), (unknown), (unknown), Audrey Lardy-Cléaud, Sylvie Chabaud	6
3	Head and neck INI1-deficient carcinoma without primary: a case report 2023 ·Journal of Medical Case Reports ·(unknown), (unknown), Laurence Bozec, (unknown), Olivier Choussy	1
4	Advanced cancer and COVID-19 comorbidity: medical oncology-palliative medicine ethics meetings in a comprehensive cancer centre 2021 ·BMJ Supportive & Palliative Care ·(unknown), (unknown), Perrine Vuagnat, (unknown), Sylvie Dolbeault, Alexis Burnod, (unknown), (unknown), Marie-Ange Massiani, Laurence Bozec, François‐Clément Bidard, Paul Cottu, (unknown), Carole Bouleuc	6
5	S’adapter face à la pandémie SARS-CoV2 : l’expérience de l’Institut Curie 2021 ·Bulletin du Cancer ·(unknown), (unknown), Alexis Burnod, Paul Cottu, Laurence Bozec, (unknown), (unknown), (unknown), (unknown), P. Fumoleau, Carole Bouleuc	1
6	Première vague COVID-19 : expérience d’un centre de lutte contre le cancer 2021 ·Bulletin du Cancer ·Maxime Frélaut, (unknown), Perrine Vuagnat, Laurence Bozec, Pauline Moreau, Irène Kriegel, D. Vanjak, Hervé J. Brisse, Carole Bouleuc, Paul Cottu	1
7	COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area 2020 ·Breast Cancer Research ·(unknown), Perrine Vuagnat, Maxime Frélaut, Toulsie Ramtohul, Clémence Basse, (unknown), (unknown), Audrey Bellesœur, Vincent Servois, Delphine Héquet, Enora Laas, Youlia Kirova, Luc Cabel, (unknown), Laurence Bozec, Xavier Paolettí, Paul Cottu, (unknown)	80
8	Clinical Implications of 18F-FDG PET/CT in Malignant Glomus Tumors of the Esophagus 2020 ·Clinical Nuclear Medicine ·Romain‐David Seban, Laurence Bozec, Laurence Champion	5
9	Metabolic Response by 18F-FDG PET/CT in Metastatic Malignant Struma Ovarii Treated With Targeted Therapies 2020 ·Clinical Nuclear Medicine ·Romain‐David Seban, Laurence Bozec, (unknown), Laurence Champion	1
10	A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study) 2019 ·European Journal of Cancer ·Patricia Pautier, Nicolas Penel, Isabelle Ray‐Coquard, Antoîne Italiano, Emmanuelle Bompas, Corinne Delcambre, Jacques‐Olivier Bay, François Bertucci, (unknown), Christine Chevreau, Didier Cupissol, Laurence Bozec, Jean-Christophe Eymard, Esma Saâda, Nicolás Isambert, Cécile Guillemet, María Rios, Sophie Piperno‐Neumann, (unknown), Florence Duffaud	19
11	Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution 2018 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), Emmanuelle Fourme, (unknown), Laurence Bozec, Florence Lerebours, Coraline Dubot, Okba Bensaoula, (unknown), Jean‐Yves Pierga, D. Lefeuvre	7
12	Diagnosis of sinusoidal obstruction syndrome by positron emission tomography/computed tomography: Report of two cases treated by defibrotide 2014 ·Hepatology ·Mathieu Gauthé, Laurence Bozec, Pierre Bédossa	8
13	Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival 2013 ·Annals of Oncology ·Delphine Garbay, Robert G. Maki, Jean‐Yves Blay, Nicolás Isambert, (unknown), (unknown), Elisa Zanardi, Pascaline Boudou‐Rouquette, Laurence Bozec, Florence Duffaud, François Bertucci, Antoîne Italiano	34
14	Gemcitabine and epirubicin in patients with metastatic breast cancer: A phase I/II study 2006 ·The Breast ·Mario Campone, P. Fumoleau, (unknown), Véronique Dièras, Éric Pujade-Lauraine, Daniel Serin, Thierry Petit, Marc Espié, L. Kayitalire, Laurence Bozec, P Pouillart	2
15	First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study 2005 ·BMC Cancer ·Djelila Allouache, (unknown), M. Tubiana-Hulin, N. Tubiana-Mathieu, Sophie Piperno‐Neumann, F. Mefti, Laurence Bozec, (unknown)	20
16	Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer 2004 ·Clinical Cancer Research ·Christian Monnerat, Thierry Le Chevalier, Karen Kelly, Coleman K. Obasaju, Julie R. Brahmer, Silvia Novello, Takashi Nakamura, Astra M. Liepa, Laurence Bozec, Paul A. Bunn, David S. Ettinger	41
17	Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors 2004 ·Annals of Oncology ·J. L. Misset, Érick Gamelin, Mario Campone, Suzette Delaloge, Jane E. Latz, Laurence Bozec, P. Fumoleau	26
18	Cellular pharmacology of the combination of oxaliplatin with topotecan in the IGROV-1 human ovarian cancer cell line 1999 ·Anti-Cancer Drugs ·François Goldwasser, Laurence Bozec, (unknown), Jean-Louis Misset	26
19	Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer 1999 ·Annals of Oncology ·J. L. Misset, Véronique Dièras, G. Gruia, Hugues Bourgeois, Esteban Cvitkovic, Salima Kalla, Laurence Bozec, Philippe Beuzeboc, C Jasmin, (unknown), A. Riva, N. Azli, P Pouillart	106
20	Irinotecan-induced immune thrombocytopenia 1998 ·Annals of Oncology ·Laurence Bozec, Philippe Bierling, Patricia Fromont, Fabio Levi, Pierre Debat, Esteban Cvitkovic, J.L. Misset	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact